Native T1 mapping in transthyretin amyloidosis

JACC: Cardiovascular Imaging

Volumn 7, Issue 2, 2014, Pages 157-165

  Fontana, Marianna ^a,b   Banypersad, Sanjay M ^a,b   Treibel, Thomas A ^a,b   Maestrini, Viviana ^a,c   Sado, Daniel M ^a,b   White, Steven K ^a,b   Pica, Silvia ^a   Castelletti, Silvia ^a   Piechnik, Stefan K ^d   Robson, Matthew D ^d   Gilbertson, Janet A ^b   Rowczenio, Dorota ^b   Hutt, David F ^b   Lachmann, Helen J ^b   Wechalekar, Ashutosh D ^b   Whelan, Carol J ^b   Gillmore, Julian D ^b   Hawkins, Philip N ^b   Moon, James C ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

amyloidosis; cardiac magnetic resonance; T1 mapping; transthyretin

Indexed keywords

AMYLOIDOSIS; COMPARATIVE STUDY; FEMALE; HEART DISEASES; HUMAN; MALE;

AMYLOIDOSIS; FEMALE; HEART DISEASES; HUMANS; MALE;

EID: 84893877279     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.10.008     Document Type: Article

References (22)

1. G.G. Cornwell 3rd, W.L. Murdoch, R.A. Kyle, P. Westermark, and P. Pitkanen Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation Am J Med 75 1983 618 623 (Pubitemid 13012155)
2. T. Yamashita, K.H. Asl, M. Yazaki, and M.D. Benson A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population Amyloid 12 2005 127 130 (Pubitemid 40978722)
3. J. Buxbaum, D.R. Jacobson, and C. Tagoe et al. Transthyretin V122I in African Americans with congestive heart failure J Am Coll Cardiol 47 2006 1724 1725
4. D.R. Jacobson, R.D. Pastore, and R. Yaghoubian et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans N Engl J Med 336 1997 466 473 (Pubitemid 27074357)
5. J.H. Pinney, C.J. Whelan, and A. Petrie et al. Senile systemic amyloidosis: clinical features at presentation and outcome JAMA 2 2013 e000098
6. J.H. Pinney, C.J. Smith, and J.B. Taube et al. Systemic amyloidosis in England: an epidemiological study Br J Haematol 161 2013 525 532
7. F.L. Ruberg, and J.L. Berk Transthyretin (TTR) cardiac amyloidosis Circulation 126 2012 1286 1300
8. E. Perugini, P.L. Guidalotti, and F. Salvi et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2- propanodicarboxylic acid scintigraphy J Am Coll Cardiol 46 2005 1076 1084 (Pubitemid 41316518)
9. A.M. Maceira, J. Joshi, and S.K. Prasad et al. Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 2005 186 193 (Pubitemid 40139730)
10. G. Di Bella, F. Minutoli, and A. Mazzeo et al. MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy AJR Am J Roentgenol 195 2010 W394 W399
11. T.D. Karamitsos, S.K. Piechnik, and S.M. Banypersad et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis J Am Coll Cardiol Img 6 2013 488 497
12. M.A. Gertz, R. Comenzo, and R.H. Falk et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004 Am J Hematol 79 2005 319 328 (Pubitemid 41098849)
13. P. Elliott, B. Andersson, and E. Arbustini et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 2008 270 276
14. C.M. Kramer, J. Barkhausen, S.D. Flamm, R.J. Kim, and E. Nagel Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols J Cardiovasc Magn Reson 10 2008 35
15. M. Fontana, S.K. White, and S.M. Banypersad et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR J Cardiovasc Magn Reson 14 2012 88
16. F.L. Ruberg T1 mapping in cardiac amyloidosis: can we get there from here? J Am Coll Cardiol Img 6 2013 498 500
17. S.M. Banypersad, D.M. Sado, and A.S. Flett et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study Circ Cardiovasc Imaging 6 2013 34 39
18. S.W. Dubrey, K. Cha, M. Skinner, M. LaValley, and R.H. Falk Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes Heart 78 1997 74 82 (Pubitemid 27346885)
19. J. Shi, J. Guan, and B. Jiang et al. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway Proc Natl Acad Sci U S A 107 2010 4188 4193
20. C. Rapezzi, C.C. Quarta, and P.L. Guidalotti et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis J Am Coll Cardiol Img 4 2011 659 670
21. C.Y. Liu, Y.C. Liu, and C. Wu et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 62 2013 1280 1287
22. S.K. Piechnik, V.M. Ferreira, and A.J. Lewandowski et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI J Cardiovasc Magn Reson 15 2013 13